The current valuation score of Eledon Pharmaceuticals Inc is 6.46, ranking 298 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.12, which is -367.01% below the recent high of 11.00 and -1876.83% above the recent low of -81.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.